Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00905515 · ClinicalTrials.gov registry record · Phase 4
Optima: Optimizing Prograf Therapy in Maintenance Allografts II
A Phase 4 study, sponsored by East Carolina University.
- Completed
- Registry status
- Phase 4
- Development phase
- 63
- Enrollment target
NCT00905515: Completed Phase 4 study, sponsored by East Carolina University.
NCT00905515 is a Phase 4 study that has completed, run by East Carolina University. The registered enrollment target is 63 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00905515, a Phase 4 study, has completed, sponsored by East Carolina University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 63 participants
- Enrollment target
Study Summary
This study is designed to optimize calcineurin immunosuppressive regimens and evaluate immunological and non-immunological markers that may explain mechanistic differences in these agents and their effects.
Interventions
- DRUG cyclosporine
- DRUG Prograf (Tacrolimus)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2003-08 |
| Est. Completion | 2008-07 |
| Phase | Phase 4 |
What the finished NCT00905515 record still lists
NCT00905515 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which cyclosporine is the first listed.
NCT00905515 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00905515 about?
NCT00905515 is a clinical study titled "Optima: Optimizing Prograf Therapy in Maintenance Allografts II". This study is designed to optimize calcineurin immunosuppressive regimens and evaluate immunological and non-immunological markers that may explain mechanistic differences in these agents and their effects.
What is the current status of trial NCT00905515?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 63 participants. The study started on 2003-08. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00905515?
The interventions under investigation include: cyclosporine (DRUG), Prograf (Tacrolimus) (DRUG).
Who is sponsoring clinical trial NCT00905515?
This trial is sponsored by East Carolina University, which has 58 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00905515's enrollment target sits among peer trials
63 1106th of 2000 higher than 891 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03383575 · 63 participants · Phase 2
Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome
- NCT04870944 · 63 participants · Phase 1
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- NCT05031897 · 63 participants · Phase 2
Two Step Haplo With Radiation Conditioning
- NCT05312671 · 63 participants · Phase 2
Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia